-
Article
Open AccessDetecting high-risk neighborhoods and socioeconomic determinants for common oral diseases in Germany
Ideally, health services and interventions to improve dental health should be tailored to local target populations. But this is not the standard. Little is known about risk clusters in dental health care and t...
-
Article
Open AccessEffects of whole body vibration in postmenopausal osteopenic women on bone mineral density, muscle strength, postural control and quality of life: the T-bone randomized trial
Osteopenia is common in postmenopausal women and effective interventions increasing or stabilizing bone mineral density (BMD) to prevent fractures are urgently needed.
-
Article
Open AccessA case report of COVID-19 monitoring in the Austrian professional football league
Since the beginning of the COVID -19 pandemic, many contact sport teams are facing major challenges to safely continue training and competition. We present the design and implementation of a structured monitor...
-
Article
Open AccessCitizens, doctors, politicians - who´s an expert in times of COVID-19? A survey in Austria and Germany
This study aimed to explore which measures and risk factors for a COVID − 19 infection are considered most important in the general population, health experts and policymakers and to assess the level of agreem...
-
Article
A Simple Prioritization Table for Managing Polypharmacy in Primary Care Patients (PRIO PC) — a Pilot Study
Polypharmacy has become a global health problem. Numerous interventions to reduce polypharmacy have been published in the past years, but applicable best practice models are missing. The prioritization table i...
-
Chapter and Conference Paper
Assessing the Energy Use and Carbon Dioxide Emissions of Maritime Infrastructure Projects
The construction of maritime infrastructure, such as waterways and seaports, often require large-scale dredging processes. These processes are often both energy-intensive, using various fuels and emit conside...
-
Article
Open AccessPolypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
Polypharmacy is common in older people and associated with potential harms. The aim of this study was to analyse the characteristics of an older multimorbid population with polypharmacy and to identify factors...
-
Article
Open AccessMultiprofessional COPD care in Austria–challenges and approaches
Chronic obstructive pulmonary disease (COPD) is a frequent disease of the lungs. Its prevalence was estimated to be 26% in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) I and 11% for GOLD I...
-
Article
Open AccessThe impact of a disease management programme for type 2 diabetes on health-related quality of life: multilevel analysis of a cluster-randomised controlled trial
Type 2 diabetes is a chronic disease associated with poorer health outcomes and decreased health related quality of life (HRQoL). The aim of this analysis was to explore the impact of a disease management prog...
-
Article
Open AccessEffectiveness and safety of beta blockers in the management of hypertension in older adults: a systematic review to help reduce inappropriate prescribing
The benefit from a blood pressure lowering therapy with beta blockers may not outweigh its risks, especially in older populations. The aim of this study was to look for evidence on risks and benefits of beta bloc...
-
Article
Open AccessPolypharmacy in chronic diseases–Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial
Multimorbidity is increasing in aging populations with a corresponding increase in polypharmacy as well as inappropriate prescribing. Depending on definitions, 25-50 % of patients aged 75 years or older are ex...
-
Article
Effectiveness of the Austrian disease management programme “Therapie Aktiv” for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up
We evaluated the disease management programme (DMP) “Therapie Aktiv” for diabetes mellitus type 2 during the first year of implementation in a cluster-randomised controlled trial (RCT), which revealed an impro...
